$BDPTD .06 One-for-One Stock Dividend
All Content and Data provided by Third-Parties — Terms of Use
BioAdaptives, Inc.’s Board of Directors Approves a One-for-One Stock Dividend
GLOBENEWSWIRE 9:15 AM ET 12/3/2024
Symbol Last Price Change
BDPTD 0.06down 0 (0%)
QUOTES AS OF 10:09:48 AM ET 12/03/2024
LAS VEGAS, Dec. 03, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc.(BDPTD) Board of Directors has approved a dividend to all common stockholders. They will receive matching shares for all of the shares they own on the Record Date.
CEO James Keener stated, “This dividend is designed to acknowledge your steadfast belief in our vision and to reward you for standing by us as valued stakeholders.”
Key Details:
Dividend Structure: One additional share of common stock for each share owned as of the record date.
Record Date: Projected for the second week of January 2025
Payment Date: Within 15 days from the Record Date
Keener added, “This special dividend aligns with our dedication to enhancing shareholder value while reinforcing our focus on long-term growth and success. The additional shares you will receive signify our shared optimism for the future and our determination to deliver results that benefit all stakeholders.”
About BioAdaptives, Inc.(BDPTD)
BioAdaptives, Inc. (BDPTD) is a leader in the nutritional products industry, committed to delivering innovative solutions that enhance quality of life, anti-aging, cell repair, and well-being. With a deep focus on research, customer insights, and sustainable practices, BioAdaptives Inc.(BDPTD) redefines what customers can expect from nutritional products. For more information, visit www.bioadaptives.com.
Forward-Looking Statements:
This press release contains forward-looking statements, including those related to the anticipated performance and success of the new product line. These statements are subject to risks and uncertainties that could materially cause actual results to differ. Please refer to our filings with the Securities and Exchange Commission for more information on potential risks.
Contact:
Emily Harrison
Investor Relations
BioAdaptives, Inc.(BDPTD)
659-8829
Info@bioadaptives.com
Wire Service Contact:
IBN
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
Image: https://www.globenewswire.com/newsroom/ti?nf=OTMxMjk2NCM2NjE5NjI5IzUwMDEyNTE3Mg==
Image: https://ml.globenewswire.com/media/MTY1M2NlMmYtMDZiZC00YmQxLWE1NzUtYTA2YmFkMGM1MjdiLTUwMDEyNTE3Mg==/tiny/BioAdaptives-Inc-.png
Image: Primary Logo
Source: BioAdaptives Inc.(BDPTD)
2024 GlobeNewswire, Inc.
News 
Market Data 
Discover 
AI
